Cite
HARVARD Citation
Kadowaki, T. et al. (2021). A randomized, placebo‐controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control. Diabetes, obesity & metabolism. 23 (6), pp. 1242-1251. [Online].